Mar 8, 2016 by Brian FeroldiWhy Omeros Corporation Dropped 12% in FebruaryShares plunged despite the company seeing an increase in demand for one of its clinical compounds.
Mar 8, 2016 by Brian Feroldi, Sean Williams, and Cheryl SwansonKiss Patent Protection Goodbye for These 3 Blockbuster Drugs in 2016These three drugs could be losing patent protection in the next 12 months.
Mar 7, 2016 by Brian Feroldi, Selena Maranjian, and Jordan Wathen3 Beaten-Down Stocks Ready to Bounce BackOur team of Motley Fool contributors thinks these three stocks look poised for a strong recovery.
Mar 7, 2016 by Brian FeroldiWhy Adamas Pharmaceuticals Dropped 25.3% in FebruaryBetter than expected fourth quarter results couldn't keep traders from dumping the company's stock.
Mar 7, 2016 by Brian FeroldiWhy Teligent Inc. Plunged 18.5% in FebruaryShares tumbled despite the company reporting two positive developments during the month.
Mar 6, 2016 by Brian FeroldiRepligen Corporation Jumped 14.6% in February -- Here's WhyA solid earnings report, mixed with the extension of a key supply agreement, sends shares higher.
Mar 6, 2016 by Brian FeroldiWhy Acadia Healthcare Company Inc. Dropped 10.4% in FebruaryMixed results from the company's fourth-quarter earning report sends shares plunging.
Mar 6, 2016 by Brian Feroldi, Tyler Crowe, and Daniel MillerSmart Investors Are Already Buying These Stocks for RetirementWhat makes a stock a good choice for a retirement investment? Here's what our analysts have to say.
Mar 5, 2016 by Brian FeroldiLast Week's Best Healthcare ETFHealthcare stocks had another good week, and investors in this one ETF made out especially well.
Mar 5, 2016 by Brian FeroldiWhy Raptor Pharmaceutical Corp. Plunged 13.1% in FebruaryTraders sold-off the company's stock after it reported a mixed quarterly earnings report.
Mar 5, 2016 by Brian Feroldi, Sean Williams, and Cheryl Swanson3 Healthcare Stocks Short-Sellers Are Wrong AboutShort-sellers are betting big that these healthcare stocks will fall. Here's why our top healthcare contributors think their views could be wrong.
Mar 5, 2016 by Brian FeroldiLast Month's Best Healthcare ETFHealthcare investors had a rough month, but this one ETF held up better than the rest.
Mar 3, 2016 by Brian FeroldiThese 3 Biotechs Are Growing Fast -- Which Is the Best Buy Today?Which of these biotech all-stars is the best choice for new money?
Feb 29, 2016 by Brian FeroldiWhy Novavax Inc Is Tanking TodayShares drop after the company released its fourth-quarter earnings.
Feb 29, 2016 by Brian FeroldiAlexion Pharmaceuticals Inc. in 5 ChartsAlexion Pharmaceuticals released its fourth-quarter and full-year earnings on Wednesday. Here are the key facts that investors need to know.
Feb 29, 2016 by Brian FeroldiShould This Data Worry Gilead Sciences Inc.'s Investors?A new report could spell trouble for one of Gilead's hepatitis C drugs.
Feb 28, 2016 by Brian FeroldiClinical Studies and Medicare: What You Need to KnowHas your provider asked you to join a clinical research study? Here's what you need to know if you have Medicare.
Feb 28, 2016 by Brian Feroldi, Evan Niu, CFA, and Matt DiLallo3 Best Stocks for Risk-Tolerant InvestorsOur Motley Fool contributors like these high-risk stocks for the long term, and perhaps you should, too.
Feb 27, 2016 by Brian FeroldiLast Week's Best Healthcare ETFHealthcare ETFs had another great week, but the returns offered from this one ETF make it this week's top performer.
Feb 26, 2016 by Brian FeroldiMedivation Inc. Stock Is Rising Today -- Here's WhyAn earnings beat, mixed with upbeat guidance, puts the company's investors in a good mood.
